IMPROVED TREATMENTS OF CANCER RESISTANT TO TAXOIDS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15522785

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to improved treatments of cancer resistant to a molecule of the taxoid family. It also relates to methods for selecting a patient affected with a tumor for a treatment with a molecule of the taxoid family in combination with a compound inhibiting the TGF-β signalling pathway or for determining whether a patient affected with a tumor is susceptible to benefit from a treatment with a molecule of the taxoid family in combination with a compound inhibiting the TGF-β signalling pathway as well as methods for screening or identifying a compound suitable for improving the treatment of a cancer with a molecule of the taxoid family or for reducing the resistance development during the treatment. The invention also relates to kits for performing these methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT GUSTAVE ROUSSYVILLEJUIF

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHAUCHEREAU, ANNE FONTENAY-AUX-ROSES, FR 6 69
MARTIN, NICOLAS JEAN-PAUL LES MUREAUX, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation